FDA核准Zulresso（brexanolone）作為產後憂鬱的治療劑
- 3月 26 週二 201923:14
FDA approves Zulresso as first treatment for post-partum depression
FDA核准Zulresso（brexanolone）作為產後憂鬱的治療劑
- 9月 02 週日 201806:05
[FDA Approvals] FDA Approves Pifeltro and Delstrigo for HIV
The US Food and Drug Administration (FDA) has approved two new oral treatments for adults with HIV-1 infection, Pifeltro and Delstrigo, both from Merck & Co, according to a company news release.
- 8月 28 週二 201811:30
[FDA Approvals] FDA Clears First Tretinoin Lotion for Acne (Altreno)
The US Food and Drug Administration (FDA) has approved once-daily tretinoin 0.05% lotion (Altreno, Ortho Dermatologics) for treatment of acne vulgaris in patients aged 9 years and older, making it the first tretinoin product to be available in lotion form.
- 6月 29 週五 201806:00
[FDA] FDA Approves Plazomicin (Zemdri) for Urinary Tract Infections
Achaogen Inc said on Tuesday U.S. health regulators cleared its antibiotic Zemdri (plazomicin) to treat adults with complicated urinary tract infections, but declined approval for treating bloodstream infections.
- 6月 06 週三 201809:00
[FDA]FDA Approves First Nonopioid Drug Lucemyra for Opioid Withdrawal
The US Food and Drug Administration (FDA) has approved lofexidine hydrochloride (Lucemyra, US WorldMeds), a nonopioid, for the mitigation of symptoms in the setting of abrupt opioid withdrawal in adults.
- 6月 05 週二 201809:00
[FDA]FDA Approves Lokelma for Hyperkalemia
The US Food and Drug Administration (FDA) has approved sodium zirconium cyclosilicate (Lokelma, AstraZeneca) — a medication that rapidly restores normal potassium levels — for adults with hyperkalemia.
- 6月 03 週日 201809:00
[FDA]FDA OKs Asthma Inhaler Arnuity Ellipta for Kids as Young as 5 Years
The US Food and Drug Administration (FDA) has expanded the use of the inhaled corticosteroid fluticasone furoate (Arnuity Ellipta, GlaxoSmithKline) as a once-daily asthma maintenance treatment for children as young as age 5 years.
- 6月 02 週六 201809:11
[FDA]FDA Approves Imvexxy for Moderate to Severe Dyspareunia
The US Food and Drug Administration (FDA) has approved estradiol vaginal inserts (Imvexxy, TherapeuticsMD) for women with moderate to severe dyspareunia (vaginal pain during sex) resulting from menopause.
- 2月 23 週五 201821:03
[FDA Alert]Clarithromycin Risky in Patients With Heart Disease
Healthcare providers should exercise caution when prescribing the macrolide antibiotic clarithromycin (Biaxin, generics) to patients with coronary heart disease because of a potential increased risk for heart problems or death that can occur years later, the US Food and Drug Administration (FDA) said today in a safety communication.
- 11月 10 週五 201715:30
[FDA Approval]Prevymis™ (letermovir) for Prevention of Cytomegalovirus (CMV) Infection
Merck Receives FDA Approval of PREVYMIS™ (letermovir) for Prevention of Cytomegalovirus (CMV) Infection and Disease in Adult Allogeneic Stem Cell Transplant Patients
醫藥類 (14)